Interleukin-1 (IL-1) is commonly found at tumor sites and is considered one of the most important cytokines of the TME, where it plays a key role in carcinogenesis and tumor progression [6], and its expression has been associated with poor prognosis in cancer patients [7]. Here, IL1A is linked to neoplasm.